This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Epinephrine Auto-Injectors Market

Market Insights on Epinephrine Auto-Injectors covering sales outlook, demand forecast & up-to-date key trends

Epinephrine Auto-Injectors Market by End-User, Dosage, Age Group & Region - Forecast 2022 - 2032

Epinephrine Auto-Injectors Market Outlook (2022-2032)

[301 Pages Report] The market for epinephrine auto-injectors is estimated to reach USD 3.2 billion by 2032, up from USD 2 billion in 2022, at a CAGR of 4.9% between 2022 and 2032.

"Increasing government and insurance agency assistance for generic drugs could drive epinephrine auto-injectors market expansion."

Attributes

Details

Epinephrine Auto-Injectors Market CAGR (2022-2032)

4.9%

Epinephrine Auto-Injectors Market Size (2022)

US$ 2.0 Billion

Epinephrine Auto-Injectors Market Size (2032)

US$ 2.54 Billion

The epinephrine auto-injector market future trends are projected to be positive. In response to changing clinical and patient demands, syringes and injectors have evolved dramatically, resulting in increased demand for epinephrine auto-injectors.

The epinephrine auto-injectors market share is quickly increasing. The increased incidence of allergies among people has been a major driver of the epinephrine auto-injector market's expansion. As a result, the increasing number of persons allergic to dust, insect bites and venom, food, and food additives has propelled the demand for epinephrine auto-injectors.

The growing demand for epinephrine auto-injectors for rapid emergency response is projected to be a major epinephrine auto-injectors market key trends and opportunities driver.

However, epinephrine adverse effects such as elevated blood pressure, headache, irregular heart rhythm in certain situations, and anxiety, among others, might stifle epinephrine auto-injectors market expansion to some amount throughout the projection period.

Epinephrine is commonly used to treat life-threatening allergic responses, restore heart rhythm, and manage asthma. This is a crucial element driving demand for epinephrine auto-injectors and is projected to contribute to epinephrine auto-injectors market adoption trends in the future.

An epinephrine auto-injector is a medical device used to provide epinephrine or adrenaline to treat anaphylaxis. They are offered as pre-filled auto injecting devices containing the medicine to be injected beneath the skin or into the muscle along the outer thigh, which results in escalated demand for epinephrine auto-injector and sales of epinephrine auto-injector.

The key element driving the epinephrine auto-injector market growth in the high dosage sector is the rising incidence of anaphylaxis in adults, particularly among the elderly. As epinephrine is considered the first-line therapy for anaphylaxis, the rising advice of large doses for adult patients by healthcare professionals (HCP) worldwide is supporting the segment's rise in the epinephrine auto-injector market adoption trends.

Furthermore, epinephrine auto-injector market participants are aiming to supply generic, low-cost medications, which is growing demand for epinephrine auto-injector treatment choices.

Customize this Report

Let us know your requirement to get
100% FREE customization

What is the COVID-19 Impact on the Epinephrine Auto-Injectors Market?

Following the pandemic, the healthcare market for epinephrine auto-injectors is likely to rise significantly. Due to lockdowns, travel bans, and company shutdowns, the COVID-19 has had an impact on the economy and sectors of several nations, along with the epinephrine auto-injector market key trend and opportunities.

The COVID-19 issue has overwhelmed many nations' public health systems, highlighting the critical need for long-term investment in health systems. As the COVID-19 epidemic spreads, the epinephrine auto-injector market growth is projected to slow.

The life sciences industry is thriving as a result of growing demand for in-vitro diagnostic goods and expanded epinephrine auto-injector market adoption trend and epinephrine auto-injector market opportunities, and research & development efforts throughout the world.

However, the medical technology and imaging industry is seeing a reduction in sales of epinephrine auto-injector as a result of fewer surgeries and delayed or protracted equipment procurement.

Furthermore, internet consultations with healthcare specialists are projected to increase the epinephrine auto-injector market share. Virtual consultations with healthcare specialists are projected to become the standard care delivery strategy following the pandemic.

Digital health will prosper in the next years as telehealth transforms medical delivery together with epinephrine auto-injector market future trends.

Furthermore, interrupted clinical trials and related medication launch delays are projected to pave the door for totally virtual testing in the future.

In the future years, new technologies like mRNA are predicted to emerge and disrupt the pharmaceutical sector. The epinephrine auto-injector market is projected to see greater vertical integration and collaborative partnerships to surge demand for epinephrine auto-injector market and sales of epinephrine auto-injector.

What is Propelling the Epinephrine Auto-Injectors Market?

The increasing prevalence of allergies, growing awareness about allergies, technological developments in R&D activities such as chlorofluorocarbon-free epinephrine auto-injector inhalers using hydrofluoroalkane propellant, and high demand for epinephrine auto-injector instead of conventional devices such as standard syringes are the major factors driving the epinephrine auto-injector market key trends and opportunities.

A rise in new product approvals and new product launches by leading epinephrine auto-injector market legacy players is projected to fuel the epinephrine auto-injector market during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Restraints the Epinephrine Auto-Injectors Market?

Adverse side effects of excessive epinephrine auto-injector use, such as cardiac arrhythmia, pulmonary edoema, vomiting, brain haemorrhage, and so on, might represent an epinephrine auto-injector market issue.

However, regulatory barriers and hefty expenses limit the epinephrine auto-injector market expansion.

The epinephrine auto-injector market growth is projected to be hampered by a rise in the demand for alternate medication administration routes and the introduction of nasal epinephrine sprays.

The development of epinephrine auto-injector for diverse drug viscosities, as well as a lack of sufficient training for operating auto-injectors, is expected to provide challenges to the epinephrine auto-injector market adoption trends.

What are the Trends in the Epinephrine Auto-Injectors Market?

During the projection period, a high number of patient assistance programmes and the development of novel products by leading suppliers give multiple chances for epinephrine auto-injector market expansion.

Drug distribution has been an important aspect in increasing people's quality of life in recent years. Syringes and injectors have developed significantly in response to evolving clinical and patient needs. As disposable drug injectors are more convenient to use than previous techniques, they have provided possibilities for epinephrine auto-injector drug makers.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Comparative View of Adjacent Epinephrine Auto-Injectors Market

Epinephrine Auto-Injectors Market:

Attributes

Epinephrine Auto-Injectors Market

CAGR (2022-2032)

4.9%

Market Value (2026)

US$ 2.54 Billion

Growth Factor

One of the primary factors fueling the growth of the auto injectors market is the increasing frequency of targeted treatments.

Opportunity

The spike in investments in the form of funding and grants for therapies related with auto injectors accelerates market expansion.

Key Trends

The growing desire for self-administration will further extend the auto injectors industry.

Wearable Injectors Market:

Attributes

Wearable Injectors Market

CAGR (2022-2032)

9.9%

Market Value (2026)

USD 12.75 Billion

Growth Factor

COVID-19 has resulted in a shift in healthcare delivery toward homecare.

Opportunity

Increasing demand for biologics and monoclonal antibodies

Key Trends

During this epidemic, the use of wearable injectors for the administration of cancer medications and other maintenance treatments that are now in clinical studies has gained traction.

Contrast Media Injectors Market:

Attributes

Contrast Media Injectors Market

CAGR (2022-2032)

7.4%

Market Value (2026)

USD 2.19 billion

Growth Factor

As the number of cancer and CVD patients rises, so will the demand for better healthcare facilities and advanced diagnostic imaging methods, driving the market for contrast media injectors.

Opportunity

A substantial number of contrast agent approvals

Key Trends

Government organisations' rising investments, finances, and grants are propelling the contrast media injectors industry forward.

What is the Segmentation Outlook of the Epinephrine Auto-Injectors Market?

The epinephrine auto-injector market is divided into dosage, age group, end user, and geographical segments. 

The epinephrine auto-injector market is divided into three dose levels: 0.15mg, 0.3mg, and others. 

The epinephrine auto-injector market is divided into three age groups: 0-4 Years, 5-14 Years, 15-24 Years, 25-49 Years, 50-64 Years, and Above 65 Years. 

The epinephrine auto-injector market is split into hospitals, clinics, and home care based on end user. Geographically, the epinephrine auto-injector market has been examined in North America, Europe, Asia-Pacific, MEA, Latin America, and the Caribbean.

Which is the Leading Segment in the Epinephrine Auto-Injectors Market by Dosage?

The global epinephrine auto-injector market may be classified into three segments based on dosage--0.15 mg, 0.30 mg, and 0.50 mg.

During the forecast period, the 0.30 mg sector of the worldwide epinephrine auto-injector market future trends is expected to increase rapidly.

During the projection period, the category is likely to be driven by an increase in the volume sales of epinephrine auto-injectors.

Which is the Leading Segment in the Epinephrine Auto-Injectors Market by End User?

The global epinephrine auto-injector market may be divided into hospitals, clinics, home care, and others based on end-user.

During the projected period, the home care segment of epinephrine auto-injector market is likely to present considerable prospects.

During the projection period, the home care segment is likely to be driven by an increase in demand for self-management of anaphylaxis.

Which is the Leading Region in the Epinephrine Auto-Injectors Market?

Regions

CAGR (2022-2032)

United States

4.7%

United Kingdom

3.6%

China

4.2%

Japan

3.3%

South Korea

2.8%

The worldwide epinephrine auto-injector market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. During the forecast period, North America is expected to lead the worldwide epinephrine auto-injector market.

The market for epinephrine auto-injectors is dominated by North America. This business is thriving in this region as a result of the increased use of more expensive auto-injectors over traditional injecting techniques, as well as enhanced healthcare facilities.

Whereas Asia Pacific is expected to develop at the fastest CAGR during the forecast period due to an increase in the number of individuals suffering from allergies and increased awareness of auto-injectors among end-users. Rapid epinephrine auto-injector market growth may be witnessed in nations such as China and India.

The rising number of people suffering from various types of allergies, the availability of low-cost generic epinephrine auto-injectors, and the high rate of adoption of epinephrine auto-injectors in the United States are expected to drive the regional epinephrine auto-injector market share during the forecast period.

According to research published in the JAMA Network 2019, roughly 10.8% of adults in the United States, or more than 26 million people, are food allergic; yet, approximately 19% of persons believe they have a food allergy.

How Competition Influences the Epinephrine Auto-Injectors Market?

Adamis Pharmaceuticals Corporation, Alk-Abello A/S, Impax Laboratories, Inc., Mylan N.V., and Antares Pharma are among the leading players in epinephrine auto-injector market.

To acquire a competitive advantage in the epinephrine auto-injector market, the epinephrine auto-injector market’s top companies are working on extending their client base. As a result, suppliers are embarking on a number of strategic activities, including collaborations, acquisitions & mergers, and partnerships.

Recent Developments

NEW LAUNCHES:

  • Alerje Inc., a food allergy management firm located in Detroit, developed a smartphone case with an auto-injector that swiftly administers epinephrine for severe allergic responses in June 2021. When a dosage is removed from the case, the Alerje smartphone app will instantly change the patients' support circle.
  • Antares Pharma (US) struck an arrangement with Lunatus Global Medical Supplies in August 2020. (Dubai). Antares will deliver packaged goods to Lunatus under this arrangement, and Lunatus will submit and get regulatory permission for XYOSTED in the UAE and Saudi Arabia, as well as promote, market, and distribute XYOSTED in these two countries.
  • Teva Pharmaceuticals gained FDA permission in August 2018 to commercialise its generic epinephrine auto-injector in two strengths, 0.3 mg and 0.15 mg, in the United States.

ACQUISITION:

  • SHL Medical (Switzerland) bought Weibel CDS in March 2020. (Switzerland). The goal of this purchase was to increase SHL Medical's capacity to develop more sophisticated medication delivery systems based on human-centered designs and functionality.

EXTENSION:

  • Eli Lilly spent USD 470 million and generated approximately 460 new jobs in Durham, NC in January 2020. With this extension, North Carolina's research triangle park gained a new state-of-the-art pharmaceutical production plant.
  • Becton, Dickinson and Company (US) introduced a disposable autoinjector, the BD Intevia 1ml Disposable Auto-injector, in November 2019. This action will help to expand the company's auto-injector portfolio.

Key players

Key Segments

By End-User:

  • Hospitals
  • Clinics
  • Home Based
  • Others

By Dosage:

  • 0.15 mg
  • 0.3 mg
  • Others

By Age Group:

  • 0-4 Years
  • 5-14 Years
  • 15-24 Years
  • 25-49 Years
  • 50-64 Years
  • Above 65 Years

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa

Frequently Asked Questions

The epinephrine auto-injectors market is projected to have a CAGR of 4.9% in 2032.

United States is the leading region in the epinephrine auto-injectors market, with an anticipated CAGR of 4.7% by 2032.

Hospital leads the epinephrine auto-injectors market with the projected CAGR of 4.8% by 2032.

The epinephrine auto-injectors market is predicted to grow US$ 3.2 Billion by 2032.

0.3 mg led the epinephrine auto-injectors market with the projected CAGR of 4.9% by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Epinephrine Auto-Injectors

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Epinephrine Auto-Injectors Market, by Key Countries

    4.2. Epinephrine Auto-Injectors Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Patch Management Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Epinephrine Auto-Injectors Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Epinephrine Auto-Injectors Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By End-User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By End-User, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2022-2032

        8.3.1. Hospitals

        8.3.2. Clinics

        8.3.3. Home Based

        8.3.4. Others

    8.4. Market Attractiveness Analysis By End-User

9. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By Dosage

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Dosage, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage, 2022-2032

        9.3.1. 0.15 mg

        9.3.2. 0.3 mg

        9.3.3. Others

    9.4. Market Attractiveness Analysis By Dosage

10. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By Age Group

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2022-2032

        10.3.1. 0-4 Years

        10.3.2. 5-14 Years

        10.3.3. 15-24 Years

        10.3.4. 25-49 Years

        10.3.5. 50-64 Years

        10.3.6. Above 65 Years

    10.4. Market Attractiveness Analysis By Age Group

11. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By End-User

        12.4.3. By Age Group

        12.4.4. By Dosage

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By End-User

        12.5.3. By Age Group

        12.5.4. By Dosage

13. Latin America Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By End-User

        13.4.3. By Age Group

        13.4.4. By Dosage

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By End-User

        13.5.3. By Age Group

        13.5.4. By Dosage

14. Europe Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By End-User

        14.4.3. By Age Group

        14.4.4. By Dosage

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By End-User

        14.5.3. By Age Group

        14.5.4. By Dosage

15. Asia Pacific Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By End-User

        15.4.3. By Age Group

        15.4.4. By Dosage

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By End-User

        15.5.3. By Age Group

        15.5.4. By Dosage

16. Middle East and Africa Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By End-User

        16.4.3. By Age Group

        16.4.4. By Dosage

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By End-User

        16.5.3. By Age Group

        16.5.4. By Dosage

17. Key Countries Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Epinephrine Auto-Injectors Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By End-User

            17.2.2.2. By Age Group

            17.2.2.3. By Dosage

    17.3. Canada Epinephrine Auto-Injectors Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By End-User

            17.3.2.2. By Age Group

            17.3.2.3. By Dosage

    17.4. Mexico Epinephrine Auto-Injectors Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By End-User

            17.4.2.2. By Age Group

            17.4.2.3. By Dosage

    17.5. Brazil Epinephrine Auto-Injectors Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By End-User

            17.5.2.2. By Age Group

            17.5.2.3. By Dosage

    17.6. Germany Epinephrine Auto-Injectors Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By End-User

            17.6.2.2. By Age Group

            17.6.2.3. By Dosage

    17.7. France Epinephrine Auto-Injectors Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By End-User

            17.7.2.2. By Age Group

            17.7.2.3. By Dosage

    17.8. Italy Epinephrine Auto-Injectors Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By End-User

            17.8.2.2. By Age Group

            17.8.2.3. By Dosage

    17.9. BENELUX Epinephrine Auto-Injectors Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By End-User

            17.9.2.2. By Age Group

            17.9.2.3. By Dosage

    17.10. UK Epinephrine Auto-Injectors Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By End-User

            17.10.2.2. By Age Group

            17.10.2.3. By Dosage

    17.11. Nordic Countries Epinephrine Auto-Injectors Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By End-User

            17.11.2.2. By Age Group

            17.11.2.3. By Dosage

    17.12. China Epinephrine Auto-Injectors Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By End-User

            17.12.2.2. By Age Group

            17.12.2.3. By Dosage

    17.13. Japan Epinephrine Auto-Injectors Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By End-User

            17.13.2.2. By Age Group

            17.13.2.3. By Dosage

    17.14. South Korea Epinephrine Auto-Injectors Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By End-User

            17.14.2.2. By Age Group

            17.14.2.3. By Dosage

    17.15. GCC Countries Epinephrine Auto-Injectors Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By End-User

            17.15.2.2. By Age Group

            17.15.2.3. By Dosage

    17.16. South Africa Epinephrine Auto-Injectors Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By End-User

            17.16.2.2. By Age Group

            17.16.2.3. By Dosage

    17.17. Turkey Epinephrine Auto-Injectors Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By End-User

            17.17.2.2. By Age Group

            17.17.2.3. By Dosage

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Adamis Pharmaceuticals Corporation

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Alk-Abello A/S

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Impax Laboratories, Inc.

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Mylan N.V.

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Antares Pharma

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Pfizer Inc.

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Kaleo, Inc.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Teva Pharmaceutical Industries Ltd.

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Bausch + Lomb UK Ltd- Emerade

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021

Table 2: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032

Table 3: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021

Table 4: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032

Table 5: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021

Table 6: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032

Table 7: Global Epinephrine Auto-Injectors Market, By Region, 2015 – 2021

Table 8: Global Epinephrine Auto-Injectors Market, By Region, 2022 – 2032

Table 9: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021

Table 10: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032

Table 11: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021

Table 12: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032

Table 13: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021

Table 14: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032

Table 15: North America Epinephrine Auto-Injectors Market, By Country, 2015 – 2021

Table 16: North America Epinephrine Auto-Injectors Market, By Country, 2022 – 2032

Table 17: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021

Table 18: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032

Table 19: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021

Table 20: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032

Table 21: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021

Table 22: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032

Table 23: Latin America Epinephrine Auto-Injectors Market, By Country, 2015 – 2021

Table 24: Latin America Epinephrine Auto-Injectors Market, By Country, 2022 – 2032

Table 25: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021

Table 26: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032

Table 27: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021

Table 28: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032

Table 29: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021

Table 30: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032

Table 31: Europe Epinephrine Auto-Injectors Market, By Country, 2015 – 2021

Table 32: Europe Epinephrine Auto-Injectors Market, By Country, 2022 – 2032

Table 33: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021

Table 34: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032

Table 35: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021

Table 36: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032

Table 37: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021

Table 38: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032

Table 39: Asia Pacific Epinephrine Auto-Injectors Market, By Country, 2015 – 2021

Table 40: Asia Pacific Epinephrine Auto-Injectors Market, By Country, 2022 – 2032

Table 41: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021

Table 42: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032

Table 43: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021

Table 44: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032

Table 45: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021

Table 46: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032

Table 47: MEA Epinephrine Auto-Injectors Market, By Country, 2015 – 2021

Table 48: MEA Epinephrine Auto-Injectors Market, By Country, 2022 – 2032

Table 49: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021

Table 50: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032

Table 51: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021

Table 52: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021

Table 54: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032

Table 55: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 – 2021

Table 56: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021

Table 58: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032

Table 59: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021

Table 60: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021

Table 62: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032

Table 63: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021

Table 64: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021

Table 66: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032

Table 67: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021

Table 68: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021

Table 70: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032

Table 71: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021

Table 72: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Epinephrine Auto-Injectors Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032

Figure 4: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032

Figure 5: Global Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032

Figure 6: Global Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032

Figure 7: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032

Figure 8: Global Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032

Figure 9: Global Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032

Figure 10: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032

Figure 11: Global Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032

Figure 12: Global Epinephrine Auto-Injectors Market Share, By Region, 2022 & 2032

Figure 13: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Epinephrine Auto-Injectors Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032

Figure 18: North America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032

Figure 19: North America Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032

Figure 20: North America Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032

Figure 21: North America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032

Figure 22: North America Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032

Figure 23: North America Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032

Figure 24: North America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032

Figure 25: North America Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032

Figure 26: North America Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032

Figure 32: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032

Figure 33: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032

Figure 34: Latin America Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032

Figure 35: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032

Figure 36: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032

Figure 37: Latin America Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032

Figure 38: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032

Figure 39: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032

Figure 40: Latin America Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032

Figure 41: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032

Figure 46: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032

Figure 47: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032

Figure 48: Europe Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032

Figure 49: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032

Figure 50: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032

Figure 51: Europe Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032

Figure 52: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032

Figure 53: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032

Figure 54: Europe Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032

Figure 55: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032

Figure 60: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032

Figure 61: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032

Figure 62: MEA Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032

Figure 63: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032

Figure 64: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032

Figure 65: MEA Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032

Figure 66: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032

Figure 67: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032

Figure 68: MEA Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032

Figure 69: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032

Figure 74: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032

Figure 75: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032

Figure 76: Asia Pacific Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032

Figure 77: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032

Figure 78: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032

Figure 79: Asia Pacific Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032

Figure 80: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032

Figure 81: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032

Figure 82: Asia Pacific Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 87: US Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 88: US Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 89: Canada Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 91: Canada Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 92: Canada Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 93: Brazil Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 95: Brazil Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 96: Brazil Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 97: Mexico Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 99: Mexico Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 100: Mexico Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 101: Germany Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 103: Germany Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 104: Germany Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 105: U.K. Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 107: U.K. Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 108: U.K. Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 109: France Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 111: France Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 112: France Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 113: Italy Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 115: Italy Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 116: Italy Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 117: BENELUX Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 119: BENELUX Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 120: BENELUX Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 121: Nordic Countries Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 123: Nordic Countries Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 124: Nordic Countries Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 125: China Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 127: China Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 128: China Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 129: Japan Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 131: Japan Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 132: Japan Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 133: South Korea Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 135: South Korea Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 136: South Korea Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 137: GCC Countries Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 139: GCC Countries Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 140: GCC Countries Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 141: South Africa Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 143: South Africa Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 144: South Africa Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Figure 145: Turkey Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Epinephrine Auto-Injectors Market Share, By End-User, 2021

Figure 147: Turkey Epinephrine Auto-Injectors Market Share, By Age Group, 2021

Figure 148: Turkey Epinephrine Auto-Injectors Market Share, By Dosage, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Epinephrine Auto-Injectors Market

Published : June 2022

Healthcare

Dopamine and Norepinephrine Reuptake Inhibitor Market

Published : September 2020

Healthcare

Auto-Injectors Market

Published : March 2017

Healthcare

Contrast Media Injectors Market

Published : February 2022

Google translate

Epinephrine Auto-Injectors Market